Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Pfizer's kidney cancer drug to be reviewed by FDA - Proactive Investors USA Canada PDF Print
Proactive Investors USA & Canada
The drug, which is designed for previously treated patients with advanced renal cell carcinoma (RCC), an advanced type of kidney cancer, was submitted for review after Pfizer reported positive results from its phase three clinical trial in May. ...
Pfizer Files With The FDA For Review Of Axitinib For Patients With Advanced

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.